Skip to main content Back to Top
Advertisement

Advocating for Impact: Pharmacy and Medically Underserved Areas Enhancement Act: An Insider’s Perspective

Broadcast Date: June 25, 2021

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

Tom Kraus talks with Nic Pottebaum, Health Policy Advisor to Senator Chuck Grassley about the Pharmacy and Medically Underserved Areas Enhancement Act and the benefits of the legislation to Medicare beneficiaries.

Take action on the Pharmacy and Medically Underserved Areas Enhancement Act by telling your members of Congress to cosponsor the provider status legislation.

SPEAKERS

Tom KrausTom Kraus is Vice President for Government Relations at ASHP. He is a graduate of University of Michigan (BS Biology), Georgetown University Law Center (Doctor Of Law), and The Johns Hopkins University (MHS, Health Policy).

Tom previously served as the Chief of Staff and Associate Commissioner for Legislation at the U.S. Food and Drug Administration. He was also a senior policy advisor to Sen. Ted Kennedy and Sen. Tom Harkin on the Senate Health, Education, Labor and Pensions Committee, where he served as Deputy Staff Director for Health.

Nic PottebaumNic Pottebaum currently serves as health policy advisor to Iowa Senator Chuck Grassley, a senior member of the U.S. Senate Finance Committee. He formerly served as Special Assistant to the President and Deputy Director of the White House Office of Intergovernmental Affairs working with our nation’s governors, lt. governors, and more than 1,500 statewide elected and appointed officials across 55 states and territories. Pottebaum has previously served as health care, tax, and public pension policy advisor to Governor Terry Branstad and Governor Kim Reynolds. Pottebaum is a graduate of the University of Iowa where he served as student body president.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.